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Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal pro-
gressive disorder characterized clinically by muscle
wasting and weakness and pathologically by the rela-
tively selective degeneration of the upper motor neu-
rons in the motor cortex and lower motor neurons in
the brain stem and spinal cord (1). Evidence of in-
creased oxidative damage in sporadic form of ALS
(SALS) and FALS (2) are not yet correlated with com-
position antioxidative defense and activities of antioxi-
dant enzymes. Our previous results (3) showed that
basic relations between the activities of antioxidant
enzymes, as well as, there coordinated action against
oxidative pressure in SALS patients were different com-
paring to healthy controls, and therefore suggests that
antioxidant cocktail based on the activities of antioxi-
dant enzyme correlation studies can be promising ad-
juvant treatment of ALS (4, 5).
In 5’10% of ALS patients there is a positive fam-
ily history of the disease and in most of them the pat-
tern of inheritance is autosomal dominanat (6). More
than 110 different mutations involving 50 of 153 amino
acid residues have been reported in the gene encoded
coper zinc superoxide dismutase (SOD1) of FALS
patients (7). Subset of these is associated with a defect
in gene encoding SOD1 account for approximately
20% of all FALS (8). Mase et al. (9) described the large
family with a relatively not severe phenotype of FALS
due to Leu144Phe SOD1 mutation. They found that
the activity of Cu,Zn SOD in red and mononuclear cells
was significantly reduced in three FALS patients (9).
We described phenotype of the six Yugoslav families
with the same mutation (10). 
Since Cu,Zn SOD is only a part of a complex of
antioxidative defense system, in this work we present
results of determination the activities of antoxidant
enzyme in erythrocytes and plasma of eleven FALS
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patients, five asymptomatic carriers and thirty-one mat-
ched healthy controls.
Material and Methods
Patients and controls
We examined the activities of antioxidant enzy-
me: coper zinc superoxide dismutase (Cu,Zn SOD,
EC 1.15.1.1.), glutathione peroxidase (GSH-Px, EC
1.11.1.9.), catalase (CAT, EC 1.11.1.6.) and glu-
tathione reductase (GR, EC 1.6.4.2.) in erythrocytes, as
well as, the activity of glutathione-S-transferase (GST,
EC 2.5.1.18) in the blood plasma of eleven Leu144Phe
FALS patients (+/+) and five asymptomatic carriers
with the same mutation without clinical signs of the dis-
ease (+/-) and control group (-/-) comprised of thirty-
one age matched controls. ALS was diagnosed using
standard criteria as suggested by the World Federation
of Neurology, Subcommittee on Motor Neuron
Disease (11). The clinical assessment using the Norris
score was obtained in FALS patients (12). These exa-
minations were provided in newly diagnosed ALS pa-
tients and at the time of the examinations, none of
patients included in the study were receiving any me-
dication. Serving as controls were a group of thirty-one
age and sex matched patients with other neurological
disorders (8 tension headache, 4 lumbar discus herni-
ation, 19 healthy controls).
Biochemical procedures
Blood samples from ALS patients and controls
were collected in heparinised glass tubes. The erythro-
cytes and plasma were separated by centrifugation (10
min, 5000 g, 4 °C). Aliquots of the three times washed
erythrocytes were lised by ice cold water. For Cu,Zn
SOD estimation hemoglobin was removed by the
method of Tsuchihashi (13), and the supernatant was
used for the analysis. Erythrocyte Cu,Zn SOD was
assayed by the method of Misra and Fridovich (14).
CAT was assayed by the procedure of Beutler (15) and
the activity was expressed in U/g Hb. GSH-Px was
determined using t-butylhydroperoxide as a substrate
(16), and the activity was expressed in mmol NADPH/
min/g Hb. GR activity was assayed as suggested by
Glatzle (17) and expressed in mmol NADPH/min/g Hb.
The hemoglobin in erythrocyte lysates was estimated
by the method of Drabkin and Austin (18). GST activi-
ty was assayed in the plasma by the method of Habig
(19), and expressed in nmol GSH/min/L plasma.
Statistical analyses
Statistical analyses were performed according to
the protocols described by Hinkle et al (20) and Manley
(21).
Results
Activities of SOD, CAT, GSH-Px GR and GST in
blood of FALS patients, asymptomatic carriers and
controls were determined.  
The mean Cu,Zn SOD activity was significantly
lower (p<0.001) and GR activities was higher
(p<0.001) in FALS patients and in asymptomatic car-
riers in comparison with controls. Activity of GSH-Px
was lower only in FALS patients than in controls
(p<0.001). 
By canonical discriminant analysis it is possible to
discriminate different categories (in this study analyzed
groups) by the composition of the antioxidative defense
components and find which component significantly
confers this difference (22). In this way, FALS patients,
asymptomatic carriers and controls were analyzed and
a single statistically significant (p<0.001) canonical
discriminant function was obtained:
D1 = 0.99 Cu,Zn SOD + 0.98 CAT + 0.92 GSH
Px + 0.98 GST ’ 0.93GR p<0.001
According to the results of canonical discriminant
function it might be concluded that all examined an-
tioxidant enzimes in erythrocytes significantly confer to
difference in antioxidant defense composition observed
between compared groups. The results of this analysis
showed that we are enable to distinguish with certainty
FALS patents, asymptomatic carriers and the controls. 
Since canonical distribution of groups is present-
ed in two-dimensional discriminant canonical space
Table I   Activities of antioxidant enzymes in FALS patients, asymptomatic assymptomatic cerriers and controls. 
Difference between groups was analysed by one-way analysis of variance (ANOVA) and post-hoc compared 
by Tukey's test for unequivocal number of examinees. Different letters (a, b) indicating presence of statistical 
significance between comparing groups.
Cu,Zn SOD
CAT
GSH-Px
GR
GST
Leu144Phe FALS patients
(+/+)  (n=11)
2830 “ 609 a
17.6 “ 3.3
14.7 “ 3.7 a
5.2 “ 0.9 a
4.1 “ 0.8
Asymptomatic carriers
(+/-) (n=5) 
2857 “ 538 a
19.3 “ 3.4
17.7 “ 2.3 ab
5.6 “ 0.7 a
4.6 “ 1.1
Controls (-/-)
(n=31)
3888 “ 503 b
21.3 “ 3.6
18.7 “ 2.7 b
4.2 “ 0.9 b
5.0 “ 0.9
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(named as X and Y function), it is worth mentioning
that left canonical space is for groups carrying muta-
tion on Cu,Zn SOD, that is to say there are similarities
between them comparing to controls with adequate
Cu,Zn SOD protein.
Discussion
Our previous results in study of SALS patients
showed that disease factors changed relations between
antioxidant enzymes components and that antioxidant
defense system in ALS patients could be characterized
as different composed comparing to healthy individu-
als (3). From our present result, it is obvious that FALS
patients have exchanged antioxidant enzymes relations
in comparison with controls. Differences in response to
oxidative stress between groups of FALS patients and
asymptomatic carriers may be the cause of observed
viability in disease progression demonstrated for
Leu144Phe mutation. Viability in the age of onset, di-
sease progression, rate and initial signs of the disease,
both within and between families has been demon-
strated for the Leu144Phe mutation (5). Similar-viabili-
ty in disease progression ’ was found among sporadic
ALS patients.
Our results in this paper showed, that the Cu,Zn
SOD activity is significantly lower also in asymptomatic
carriers in comparison to controls. Cu,Zn SOD activity
determined from the hemolisate of the FALS patients
was significantly reduced when compared to the con-
trols and this is in accordance with results of Mase et al
2001 (9). We noticed in FALS patients significantly
increased of GR and decreased of GSH-Px and GST
activities in comparison with controls. Since this phe-
nomenon was not found in asymptomatic carriers, it
could be attributed to specific oxidative factors induced
in ALS pathophysiology.
Although Cu,Zn SOD activity is significantly de-
creased in asymptomatic carriers, it is not enough to
induce significant changes in the activities of other anti-
oxidant enzymes, but changes in the composition of
antioxidant defence system in asymptomatic carriers
are obvious. Pathological process in FALS patients is
correlated with further changes in antioxidant defense
composition. 
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Kratak sadr`aj: U ovom radu ispitivana je aktivnost: bakar cink sadr`avaju}e superoksid dismutaze (Cu,
Zn SOD), katalaze (CAT), glutation peroksidaze (GSH-Px), glutation reduktaze (GR) i glutation-S-transferaze
(GST) u krvi pacijenata sa familijarnim oblikom amiotrofi~ne lateralne skleroze (FALS) sa mutacijom
Leu144Phe, asimptomskim nosiocima mutacije Leu144Phe i kontrola. Aktivnost Cu,Zn SOD je statisti~ki
zna~ajno ni`a kod FALS pacijenata i asimptomskih nosioca mutacije Leu144Phe nego kod kontrola (p <
0,001). Kod FALS pacijenata aktivnost GSH-Px je ni`a (p < 0,01), a aktivnost GR je ve}a (p < 0,001) u pored-
jenju sa kontrolnom grupom. Kanonijska diskriminantna analiza obezbedjuje statisti~ku podr{ku uo~ene razlike
u sastavu antioksidacionih za{titnih enzima u krvi ispitivanih grupa i pokazuje nam da svaka komponenta
zna~ajno doprinosi toj razlici. Na{i rezultati sugeri{u da je oksidacioni stres uklju~en u patogenezu FALS i da su
antioksidacioni za{titni enzimi izlo`eni razli~itom oksidacionom pritisku kod FALS, asimptomskih nosioca
mutacije Leu144Phe i kontrola.
Klju~ne re~i: FALS, Leu144 mutacija, antioksidacioni za{titni enzimi
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